Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunological and Clinical Markers of Post‐acute Sequelae of COVID‐19: Insights from Mild and Severe Cases 6 Months Post‐infection

1 Jul 2025

Abstract excerpt

ABSTRACT Post‐acute sequelae of COVID‐19 (PASC) are a complex clinical condition that requires a better understanding of its underlying biological mechanisms. In this study, we assessed hundreds of virological, serological, immunological, and tissue damage biomarkers in two cohorts of patients who had experienced either mild ( n = 270) or severe ( n = 188) COVID‐19, 6 to 9 months post‐initial infection, and in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Long-Term Effects of COVID-19
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40629965
DOI: 10.1002/eji.202551948

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunological and Clinical Markers of Post‐acute Sequelae of COVID‐19: Insights from Mild and Severe Cases 6 Months Post‐infectionPMID 40629965Read ↗

Immunological and clinical markers of post-acute sequelae of COVID-19: Insights from mild and severe cases six months post-infectionSemantic proximity Read ↗

Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19.Semantic proximity Read ↗

Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+β7 integrin+ T cells and anti-SARS-CoV-2 IgA responseSemantic proximity Read ↗

Heterogeneous immunological recovery trajectories revealed in post-acute COVID-19Semantic proximity Read ↗

Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19Semantic proximity Read ↗

Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistenceSemantic proximity Read ↗

Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19Semantic proximity Read ↗

Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine LearningSemantic proximity Read ↗

A Longitudinal SARS-CoV-2 Biorepository for COVID-19 Survivors with and without Post-Acute SequelaeSemantic proximity Read ↗

COVID-19 Clinical Severity, T Cell-Mediated Immune Response, and Correlates of Inflammation: Not an Intuitive GuessSemantic proximity Read ↗

Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelaeSemantic proximity Read ↗

Acute COVID-19 gene-expression profiles show multiple etiologies of long-term sequelaeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.